Deals This Week: Ascendis Pharma, DanDrit Biotech USA, Pangen Biotech
Ascendis Pharma has issued American Depositary Shares (ADS) through an underwritten public offering to raise $150m.
Ascendis Pharma has issued American Depositary Shares (ADS) through an underwritten public offering to raise $150m.
Onconova Therapeutics Inc plans to raise $13.66m through a public offering of 8.65 million shares priced at $1.58 a unit.
Thank you for subscribing to Clinical Trials Arena